Dicerna Pharmaceuticals
DRNA
#4014
Rank
โ‚ฌ2.71 B
Marketcap
34,83ย โ‚ฌ
Share price
0.00%
Change (1 day)
18,172.94%
Change (1 year)

Earnings for Dicerna Pharmaceuticals (DRNA)

Earnings in 2021 (TTM): -โ‚ฌ98.9 Million

According to Dicerna Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.19 Billion. In 2020 the company made an earning of -โ‚ฌ98.77 Million, an increase over its 2019 earnings that were of -โ‚ฌ0.12 Billion.

Earnings history for Dicerna Pharmaceuticals from 2013 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-โ‚ฌ98.9 Million0.12%
2020-โ‚ฌ98.77 Million-11.52%
2019-โ‚ฌ0.12 Billion38.33%
2018-โ‚ฌ80.7 Million46.14%
2017-โ‚ฌ55.22 Million1.8%
2016-โ‚ฌ54.25 Million-5.58%
2015-โ‚ฌ57.45 Million32.01%
2014-โ‚ฌ43.52 Million171.79%
2013-โ‚ฌ16.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚ฌ6.35 B-6,022.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ10.07 B-9,493.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ6.12 B-5,814.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-โ‚ฌ43.23 Million-59.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ1.11 B-1,138.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-โ‚ฌ0.15 Billion 35.54%๐Ÿ‡บ๐Ÿ‡ธ USA